X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cervical cancer (4) 4
adolescent (3) 3
adult (3) 3
cervical intraepithelial neoplasia - prevention & control (3) 3
cervical intraepithelial neoplasia - virology (3) 3
double-blind method (3) 3
female (3) 3
humans (3) 3
index medicus (3) 3
papillomavirus infections - prevention & control (3) 3
vaccines (3) 3
adjuvants, immunologic - administration & dosage (2) 2
age factors (2) 2
analysis (2) 2
clinical trials (2) 2
follow-up (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
human papillomavirus (2) 2
human papillomavirus 16 - immunology (2) 2
human papillomavirus 18 - immunology (2) 2
oncology (2) 2
papillomavirus infections (2) 2
papillomavirus vaccines - administration & dosage (2) 2
particle vaccine (2) 2
prevention (2) 2
research (2) 2
time factors (2) 2
treatment outcome (2) 2
womens health (2) 2
young adult (2) 2
young-women (2) 2
abridged index medicus (1) 1
adenocarcinoma (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - prevention & control (1) 1
adenocarcinoma - virology (1) 1
adults (1) 1
aluminum hydroxide - administration & dosage (1) 1
asia (1) 1
australia (1) 1
autoimmune diseases (1) 1
biopsy (1) 1
broad-spectrum (1) 1
cancer (1) 1
carcinoma (1) 1
care and treatment (1) 1
case studies (1) 1
cells (1) 1
cervical intraepithelial neoplasia - diagnosis (1) 1
cervical intraepithelial neoplasia - etiology (1) 1
cervical intraepithelial neoplasia - pathology (1) 1
cervix dysplasia (1) 1
children (1) 1
classification (1) 1
costa rica (1) 1
cross infection (1) 1
demographic aspects (1) 1
deoxyribonucleic acid--dna (1) 1
dna (1) 1
dna, viral - analysis (1) 1
dna, viral - drug effects (1) 1
dna, viral - isolation & purification (1) 1
dose-response relationship, drug (1) 1
double-blind (1) 1
drug administration schedule (1) 1
epitopes (1) 1
europe (1) 1
follow-up studies (1) 1
gene expression (1) 1
hepatitis (1) 1
histology (1) 1
hpv (1) 1
hpv vaccination (1) 1
hpv vaccine (1) 1
human medicine (1) 1
human papillomavirus 16 - drug effects (1) 1
human papillomavirus 16 - genetics (1) 1
human papillomavirus 16 - isolation & purification (1) 1
human papillomavirus 16 - pathogenicity (1) 1
human papillomavirus 18 - drug effects (1) 1
human papillomavirus 18 - genetics (1) 1
human papillomavirus 18 - isolation & purification (1) 1
human papillomavirus 18 - pathogenicity (1) 1
human-papillomavirus (1) 1
human-papillomavirus infection (1) 1
identification (1) 1
immunization (1) 1
immunogenicity (1) 1
infections (1) 1
informed consent (1) 1
internal medicine (1) 1
intraepithelial neoplasia (1) 1
invasive cervical-cancer (1) 1
lipid a - administration & dosage (1) 1
lipid a - analogs & derivatives (1) 1
major capsid protein (1) 1
medical colleges (1) 1
medical research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | FOLLOW-UP | TYPE-16 | YOUNG-WOMEN | CANCER | CARCINOMA | TRENDS | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/1998, Volume 90, Issue 1, p. 43
  BACKGROUND: Among the numerous human papillomavirus (HPV) types, only types 16 and 18 have been formally classified as human carcinogens. To evaluate the... 
Case studies | Medical research | Cervical cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.